The Lipoprotein and Coronary Atherosclerosis Study (LCAS): Lipid and Metabolic Factors Related to Atheroma and Clinical Events - LCAS


The lipoprotein and coronary atherosclerosis study (LCAS) was a single-center, randomized, double-blind, placebo-controlled study to evaluate the effect of fluvastatin on reducing progression of coronary lesions as measured by quantitative coronary angiography (QCA) among patients with mildly elevated low-density lipoprotein (LDL) cholesterol.